Genelabs' Prestara Again In Trouble, This Time In Taiwan April 8, 2005 The path to market for Genelabs Technologies Inc.'s lupus drug Prestara narrowed this week when another Phase III trial failed to meet the primary endpoint. (BioWorld Today)Read More
RSS